You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《滬深兩市》上證深成半日跌1.7%至2.2% 創板低收挫逾3% 恆瑞醫藥績後跌停
人行開展100億元人民幣(下同)7天期逆回購操作,今日有100億元逆回購到期;中標利率持平於2.2%。人民幣中間價下調。上證深成今早(20日)低開後走勢持續向下,各指數走弱,其中創板更跌逾3%以半日低位收市。 上證半日跌57點或1.7%,以半日低位報3,408點;深成指跌315點或2.2%,近低收報14,171點;滬深300指數跌116點或2.4%,報4,745;創業板指數半日跌102點或3.1%,以半日低位收報3,175點,成交1,788億元。上證深成半日成交分別爲3,361億元及4,354億元。 金融股無方向,工行(601398.SH)平收。建行(601939.SH)升0.2%。平安銀行(000001.SZ)跌5.7%,其上半年營業收入按年升8.1%至846.8億元;純利按年升28.5%至175.83億元。券商股下跌,東吳證券(601555.SH)、中信建投(601066.SH)、廣發證券(000776.SZ)跌1.4%至4%。 國家市監總局價競局今早約談白酒企業,白酒股持續走弱,貴州茅臺(600519.SH)、五糧液(000858.SZ)、古井貢酒(000596.SZ)跌4.2%至5.6%。酒鬼酒(000799.SH)挫9.2%。 生物醫藥股捱沽,恆瑞醫藥(600276.SH)跌停,其上半年營業收入按年升17.58%至132.97億元,純利按年微升0.2%至26.67億元。邁瑞醫療(300760.SZ)、萬孚生物(300482.SZ)分別挫13.2%、10.3%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account